[HTML][HTML] Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor–positive non-small cell lung cancer who might benefit from …
M Provencio, R Serna-Blasco, F Franco, V Calvo… - European Journal of …, 2021 - Elsevier
Background Survival data support the use of first-line osimertinib as the standard of care for
epidermal growth factor receptor (EGFR)–positive non-small cell lung cancer (NSCLC) …
epidermal growth factor receptor (EGFR)–positive non-small cell lung cancer (NSCLC) …
Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor–positive non-small cell lung cancer who might benefit from sequential …
M Provencio, R Serna-Blasco, F Franco… - European Journal of …, 2021 - ejcancer.com
Background Survival data support the use of first-line osimertinib as the standard of care for
epidermal growth factor receptor (EGFR)–positive non-small cell lung cancer (NSCLC) …
epidermal growth factor receptor (EGFR)–positive non-small cell lung cancer (NSCLC) …
Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor-positive non-small cell lung cancer who might benefit from sequential …
M Provencio, R Serna-Blasco… - … journal of cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Survival data support the use of first-line osimertinib as the standard of care for
epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCLC) …
epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCLC) …
Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor-positive non-small cell lung cancer who might benefit from sequential …
M Provencio, R Serna-Blasco, F Franco… - European Journal of …, 2021 - europepmc.org
Background Survival data support the use of first-line osimertinib as the standard of care for
epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCLC) …
epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCLC) …
Original Research Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor-positive non-small cell lung cancer who might benefit …
M Provencio, R Serna-Blasco, F Franco… - European Journal of …, 2021 - docusalut.com
Background: Survival data support the use of first-line osimertinib as the standard of care for
epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCLC) …
epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCLC) …